18103-Prostate Cancer-NA-457

Prostate Cancer

A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer(64091742PCR3001)

  • Details

ClinicalTrials.gov ID: NCT03748641
Diagnosis Type: NA
USOR Number:

  • Address

3705 West 15th Street
Plano, TX 75075
P: (972) 867-3577

Search by practice name, trial titles, indicators and specific disease types.